US 12,012,375 B2
Prostaglandin F2 alpha derivatives for decreasing intraocular pressure
Vladimir Vilenovich Bezuglov, Moscow (RU); Igor Viktorovich Serkov, Noginsky (RU); Igor Ivanovich Lyubimov, Serpukhovsky (RU); and Nataliya Mikhailovna Gretskaya, Moscow (RU)
Assigned to GURUS BIOPHARM LIMITED LIABILITY COMPANY, Moscow (RU)
Appl. No. 17/055,838
Filed by GURUS BIOPHARM LIMITED LIABILITY COMPANY, Moscow (RU)
PCT Filed May 15, 2019, PCT No. PCT/RU2019/050062
§ 371(c)(1), (2) Date Nov. 16, 2020,
PCT Pub. No. WO2019/221641, PCT Pub. Date Nov. 21, 2019.
Claims priority of application No. RU2018118157 (RU), filed on May 17, 2018.
Prior Publication US 2021/0230111 A1, Jul. 29, 2021
Int. Cl. C07C 405/00 (2006.01); A61P 27/06 (2006.01); C07D 207/08 (2006.01)
CPC C07C 405/0041 (2013.01) [A61P 27/06 (2018.01); C07D 207/08 (2013.01)] 1 Claim
 
1. A compound selected from the following compounds:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry